37400 Federal Register / Vol. 65, No. 115 / Wednesday, June 14, 2000 / Notices

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis Panel, ZDK1 GRB 4 (01).

Date: June 16, 2000.

Time: 8:00 am to 2:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Embassy Suites Hotel, 1300

Concourse Drive, Linthicum, Maryland

21090.

Contact Person: William E. Elzinga,

Scientific Review Administrator, Review

Branch, DEA, NIDDK, Room 647, 6707

Democracy Boulevard, National Institutes of

Health, Bethesda, MD 20892–6600, (301)

594–8895.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS)

Dated: June 8, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–14960 Filed 6–13–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institute of Health

National Institute of Nursing Research;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6). Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Nursing Research Special Emphasis Panel,

NINR Career Transitional Award

Applications (K22s).

Date: June 21, 2000.

Time: 3:00 PM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Holiday Inn, 8120

Wisconsin Avenue, Bethesda, MD 20852.

Contact Person: Mary J. Stephens-Frazier,

Scientific Review Administrator, National

Institute of Nursing Research, National

Institutes of Health, Natcher Building, Room

3AN32, (301) 594–5971.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.361, Nursing Research,

National Institute of Health, HHS)

Dated: June 8, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy

[FR Doc. 00–14963 Filed 6–13–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Nursing Research;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Nursing Research Special Emphasis Panel,

NINR/ORMH Mentored Research Scientist

Development Award for Minority

Investigators (KO1s).

Date: June 21, 2000.

Time: 8:30 a.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Holiday Inn, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Mary J. Stephens-Frazier,

Scientific Review Administrator, National

Institute of Nursing Research, National

Institutes of Health, Natcher Building, Room

3AN32, Bethesda, MD 20892, (301) 594–

5971.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.361, Nursing Research,

National Institutes of Health, HHS)

Dated: June 8, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–14964 Filed 6–13–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Public Health Service

National Institute of Environmental

Health Sciences (NIEHS), National

Institutes of Health (NIH), National

Toxicology Program (NTP); Notice of

an International Workshop on In Vitro

Methods for Assessing Acute

Systemic Toxicity, co-sponsored by

NIEHS, NTP and the U.S.

Environmental Protection Agency

(EPA): Request for Data and

Suggested Expert Scientists

SUMMARY: Pursuant to Public Law 103–

43, notice is hereby given of a public

meeting sponsored by NIEHS, the NTP,

and the EPA, and coordinated by the

Interagency Coordinating Committee on

the Validation of Alternative Methods

(ICCVAM) and the NTP Interagency

Center for the Evaluation of Alternative

Toxicological Methods (NICEATM). The

agenda topic is a scientific workshop to

assess the current status of in vitro test

methods for evaluating the acute

systemic toxicity potential of chemicals,

and to develop recommendations for

future development and validation

studies. The workshop will take place

on October 17–20, 2000 at the Hyatt

Regency Crystal City Hotel, 2799

Jefferson Davis Highway, Arlington, VA,

22202. The meeting will be open to the

public.

In preparing for this Workshop,

ICCVAM is requesting: (1) Information

and data that should be considered at

the Workshop, including relevant data

on currently available in vitro methods

for assessing acute systemic toxicity;

and (2) nominations of expert scientists

to participate in the Workshop. An

agenda, registration information, and

other details will be provided in a

subsequent Federal Register notice.